University of Pennsylvania: Psoriasis trials

The registry lists 10 Psoriasis studies with University of Pennsylvania as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 2 1Phase 4 5No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Light Treatment Effectiveness (LITE) StudyCompletedNCT03726489Not applicableResults posted
• Vascular Inflammation in Psoriasis - ApremilastCompletedNCT03082729Phase 4Results posted
• Psoriasis Microbiome and PhototherapyCompletedNCT02552316Not applicableResults posted
• Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)CompletedNCT02187172Phase 4Results posted
• Vascular Inflammation in Psoriasis - Extension StudyCompletedNCT01866592Phase 4Results posted
• Vascular Inflammation in Psoriasis Trial (The VIP Trial)CompletedNCT01553058Phase 4Results posted
• Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic ArthritisActive, not recruitingNCT05908240Not applicable
• Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)CompletedNCT04535999Phase 4
• Psoriatic Arthritis and Psoriasis Treatment Decision AidCompletedNCT03737045Not applicable
• Curcuminoids for the Treatment of Chronic Psoriasis VulgarisCompletedNCT00235625Phase 2